Edition:
United States

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

4.95USD
2:15pm EST
Change (% chg)

$-0.27 (-5.17%)
Prev Close
$5.22
Open
$5.14
Day's High
$5.22
Day's Low
$4.92
Volume
7,625
Avg. Vol
10,472
52-wk High
$8.14
52-wk Low
$2.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
FY 2015 Dec '15 1.59 -0.349
Sep '15 1.07 -0.299
Jun '15 3.43 -0.125
Mar '15 0.00 -0.236
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 1.13 1.58 0.70 0.70
Quarter Ending Mar-18 2 0.70 1.40 0.00 --
Year Ending Dec-17 4 4.84 5.30 4.40 5.95
Year Ending Dec-18 4 1.95 5.00 0.00 0.50
Earnings (per share)
Quarter Ending Dec-17 4 -0.53 -0.46 -0.60 -0.65
Quarter Ending Mar-18 2 -0.52 -0.44 -0.61 --
Year Ending Dec-17 4 -1.95 -1.89 -2.03 -2.45
Year Ending Dec-18 4 -2.13 -2.00 -2.33 -2.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta -- 0.82 0.91
Price to Sales (TTM) 17.49 117.54 5.90
Price to Book (MRQ) 1.55 23.08 5.74
Price to Tangible Book (MRQ) 1.57 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 63.04 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 9.75 -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago 0.06 30.49 5.56
Sales - 5 Yr. Growth Rate -- 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -2.51 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago -9.03 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate -- 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 12.20 5.63 3.57
LT Debt to Equity (MRQ) 0.00 16.33 13.26
Total Debt to Equity (MRQ) 0.00 18.85 19.22
Interest Coverage (TTM) -- -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -530.75 -- --
EBITD - 5 Yr. Avg -- -215.54 15.70
Operating Margin (TTM) -535.16 -635.70 6.77
Operating Margin - 5 Yr. Avg. -- -232.57 11.08
Pre-Tax Margin (TTM) -527.99 -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -- -232.71 11.49
Net Profit Margin (TTM) -527.99 -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -- -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 165,633 22,216,302 857,902,259
Net Income/Employee (TTM) -874,533 -2,116,531 100,310,105
Receivable Turnover (TTM) 2.47 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.07 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -9.39 11.35
Return on Assets - 5 Yr. Avg. -- 0.13 12.32
Return on Investment (TTM) -42.37 -11.69 14.48
Return on Investment - 5 Yr. Avg. -- 3.37 16.13
Return on Equity (TTM) -42.42 -36.44 16.06
Return on Equity - 5 Yr. Avg. -- 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.30%
# of Holders: 40
Total Shares Held: 10,702,975
3 Mo. Net Change: 92,192
# New Positions: 5
# Closed Positions: 6
# Increased Positions: 13
# Reduced Positions: 15
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.